Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial

Harpreet Wasan, Angela M Meade, Richard Adams, Richard Wilson, Cheryl Pugh, David Fisher, Benjamin Sydes, Ayman Madi, Bruce Sizer, Charles Lowdell, Gary Middleton, Rachel Butler, Richard Kaplan, Tim Maughan

Research output: Contribution to journalArticle

67 Citations (Scopus)
232 Downloads (Pure)

Fingerprint Dive into the research topics of 'Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences